We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+17.84%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.61B
AUM Growth
+$110M
Cap. Flow
-$613M
Cap. Flow %
-23.5%
Top 10 Hldgs %
41.68%
Holding
110
New
10
Increased
19
Reduced
25
Closed
16

Top Buys

Rank Stock Value
1
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
+$48.5M
2
ALEC icon
Alector
ALEC
+$37M
3
IMMU
Immunomedics Inc
IMMU
+$31.6M
4
AXGN icon
Axogen
AXGN
+$30.4M
5
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$27.1M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$42.3M
2
VCEL icon
Vericel Corp
VCEL
+$37.3M
3
EHTH icon
eHealth
EHTH
+$35.1M
4
ASND icon
Ascendis Pharma A/S
ASND
+$31.6M
5
UHS icon
Universal Health Services
UHS
+$28M

Sector Composition

Rank Sector Weight
1 Healthcare 68.74%
2 Financials 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SVRA icon
76
Savara
SVRA
$1.13B
$1.84M 0.07%
250,000
– –
HYPD
77
Hyperion DeFi Inc
HYPD
$41.5M
$1.8M 0.07%
3,750
– –
VYNE icon
78
VYNE Therapeutics
VYNE
$25.4M
$1.56M 0.06%
+2,756
New +$1.32M
KIDS icon
79
OrthoPediatrics
KIDS
$493M
$1.42M 0.05%
32,000
-26,247
-45% -$998K
MLNT
80
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$1.27M 0.05%
356,952
+290,172
+435% +$1.57M
TARA icon
81
Protara Therapeutics
TARA
$230M
$616K 0.02%
30,622
– –
EYPT icon
82
EyePoint Inc
EYPT
$1.12B
$406K 0.02%
+22,680
New +$539K
ACHC icon
83
Acadia Healthcare
ACHC
$3.17B
– –
-621,000
Closed -$16M
AUTL
84
Autolus Therapeutics
AUTL
$383M
– –
-235,576
Closed -$7.74M
CTMX icon
85
CytomX Therapeutics
CTMX
$788M
– –
-622,548
Closed -$9.4M
CVS icon
86
CALL
CVS Health
CVS
$137B
– –
-566,800
Closed -$37.1M
EXAS
87
DELISTED
Exact Sciences
EXAS
– –
-129,000
Closed -$8.14M
KPTI icon
88
Karyopharm Therapeutics
KPTI
$216M
– –
-31,667
Closed -$4.45M
LIVN icon
89
LivaNova
LIVN
$4.43B
– –
-71,500
Closed -$6.54M
MNKD icon
90
MannKind Corp
MNKD
$1.25B
– –
-943,298
Closed -$1M
OCGN icon
91
Ocugen
OCGN
$460M
– –
-4,935
Closed -$26K
OPCH icon
92
Option Care Health
OPCH
$3.41B
– –
-191,750
Closed -$2.74M
VTAK icon
93
Catheter Precision
VTAK
$2.03M
– –
0
– -$862K
VYGR icon
94
Voyager Therapeutics
VYGR
$192M
– –
-117,647
Closed -$1.11M
KA
95
DELISTED
Kineta, Inc. Common Stock
KA
– –
-2,993
Closed -$1.36M
CBAY
96
DELISTED
Cymabay Therapeutics
CBAY
– –
-1,343,181
Closed -$10.6M
GWPH
97
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-109,117
Closed -$10.6M
AGN
98
DELISTED
Allergan plc
AGN
– –
-180,000
Closed -$24.1M
NVTR
99
DELISTED
Nuvectra Corporation Common Stock
NVTR
– –
-129,000
Closed -$2.11M
1 2 3
4

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q1 2019 Portfolio in Review

As of Q1 2019, Deerfield Management held 110 positions worth $2.61B, up 4.4% from $2.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Deerfield Management withdrew a net $613M in Q1 2019, closing 16 positions and reducing 25 holdings. Its most notable exit was Allergan plc, an estimated $24.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 70% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in Alector worth $36.6M.

  • Deerfield Management's largest Q1 2019 buy was Alector: 1,956,923 shares worth $36.6M.
  • Deerfield Management added most to DIPLOMAT PHARMACY, INC. in Q1 2019, an estimated $48.5M increase.
  • Deerfield Management's biggest Q1 2019 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $42.3M.
  • Deerfield Management fully exited Allergan plc in Q1 2019, selling an estimated $24.1M.
  • Deerfield Management's ten largest holdings make up 42% of its $2.61B portfolio in Q1 2019.
  • Deerfield Management opened 10 new positions and closed 16 in Q1 2019.
  • Deerfield Management's portfolio value rose 4.4% quarter-over-quarter to $2.61B.

Based on Deerfield Management's 13F filing for Q1 2019, filed 15 May 2019.